Pathbreaking treatments for rare diseases Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology. Our lead drug candidate, ADV7103, is in late-stage clinical trials for two indications: distal renal tubular acidosis (dRTA) and cystinuria. Listed on both the Euronext Paris and Euronext Brussels stock exchanges, the company is headquartered in Nîmes, France. Terms of use Privacy policy Caller Pricavy Cookies policy Youtube Contact Us 10 + 7 = SUBMIT © 2020 Advicenne Website by B-to-B Design Your privacy is important to us We use cookies for our website advicenne.com to ensure it functions correctly, improve its performance and features, measure its audience/traffic and remember your browser preferences. You can configure and deactivate cookies by clicking on « Manage cookies ». Your preferences will be saved for 12 months. You can change your decision and modify your choices at any time by clicking « Manage cookies » at the bottom of each page or by going to our « Cookies policy » by clicking the link at the bottom of each page. Accept all and access websiteManage cookiesReject all and access website

Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology. Our lead drug candidate, ADV7103, is in late-stage clinical trials for two indications: distal renal tubular acidosis (dRTA) and cystinuria. Listed on both the Euronext Paris and Euronext Brussels stock exchanges, the company is headquartered in Nîmes, France. Terms of use Privacy policy Caller Pricavy Cookies policy Youtube Contact Us 12 + 7 = SUBMIT © 2020 Advicenne Website by B-to-B Design Your privacy is important to us We use cookies for our website advicenne.com to ensure it functions correctly, improve its performance and features, measure its audience/traffic and remember your browser preferences. You can configure and deactivate cookies by clicking on « Manage cookies ». Your preferences will be saved for 12 months. You can change your decision and modify your choices at any time by clicking « Manage cookies » at the bottom of each page or by going to our « Cookies policy » by clicking the link at the bottom of each page. Accept all and access websiteManage cookiesReject all and access website